Development
Biodesix, Inc.
BDSX
$0.3029
$0.02117.49%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -52.15M | -63.35M | -66.10M | -68.56M | -65.45M |
| Total Depreciation and Amortization | 5.51M | 5.85M | 6.27M | 6.20M | 5.84M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.47M | 16.37M | 17.03M | 20.03M | 18.98M |
| Change in Net Operating Assets | 11.30M | 18.60M | 13.76M | 2.78M | -4.34M |
| Cash from Operations | -22.87M | -22.54M | -29.03M | -39.56M | -44.97M |
| Capital Expenditure | -22.92M | -21.87M | -16.80M | -10.71M | -3.30M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -143.00K | -183.00K | -180.00K | -176.00K | -236.00K |
| Cash from Investing | -23.06M | -22.05M | -16.98M | -10.89M | -3.53M |
| Total Debt Issued | 10.00M | 30.00M | 30.00M | 45.00M | 45.10M |
| Total Debt Repaid | -49.00K | -23.60M | -25.60M | -28.61M | -28.60M |
| Issuance of Common Stock | 28.86M | 57.74M | 44.24M | 58.71M | 60.16M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9.68M | -14.89M | -13.81M | -15.81M | -17.78M |
| Cash from Financing | 29.13M | 49.25M | 34.83M | 59.30M | 58.88M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.80M | 4.67M | -11.18M | 8.85M | 10.38M |